PRECISION MEDICINE FOR THE VA
Veterans will access the test at their local VA facility, and Sanford Health will process the tests at its South Dakota-based Imagenetics facility—which is overseen by former VA Secretary David Shulkin. (
Up to 250,000 veterans could receive access to no-cost pharmacogenomic testing by 2022 under a new partnership with Sanford Health. The announcement comes just months after the former secretary of the U.S. Department of Veterans Affairs took on the role of chief innovation officer at the Sioux Falls, South Dakota-based health system.
The program will launch at a pilot site in Durham, North Carolina, and will initially enroll cancer survivors, officials said. It will expand to up to 250,000 U.S. veterans at 125 sites by 2022.
PHASeR, or the Pharmacogenomics Action for Cancer Survivorship, is funded by a $25 million gift from philanthropist Denny Sanford and matching fundraising from Sanford Health.
Veterans will access the test at their local VA facility, and Sanford Health will process the tests at its South Dakota-based Imagenetics facility, officials said.
The test results will help physicians with clinical decision-making for a variety of drugs, including those for mental health, cardiovascular disease and pain management. The National Institutes of Health estimates that inappropriate treatments and adverse drug reactions cost up to $30 billion a year.
What is Precision Medicine ?
What is Precision Medicine ?
VA Secretary Robert Wilkie announces precision medicine testing initiative with Sanford Health | FierceHealthcare:
No comments:
Post a Comment